v3.22.2.2
Equity (Tables)
12 Months Ended
Oct. 31, 2022
Text Block [Abstract]  
Summary of Common and Preferred Shares and Other Equity Instruments Outstanding
The following table details our common and preferred shares and other equity instruments outstanding.

 
  
 
As at and for the year ended
 
 
October 31, 2022
 
 
 
 
 
October 31, 2021
 
               
(Millions of Canadian dollars, except the number
of shares and as otherwise noted)
 
Number of
shares
(thousands)
 
 
Amount
 
 
Dividends
declared
per share
 
 
  
 
 
Number of
shares
(thousands)
 
 
Amount
 
 
Dividends
declared
per share
 
Common shares issued
 
     
 
     
 
     
 
     
 
     
 
     
 
     
               
Balance at beginning of period
 
 
1,425,187
 
 
$
  17,728
 
                    1,423,861     $   17,628          
Issued in connection with share-based compensation plans
(1)
 
 
1,270
 
 
 
99
 
                    1,326       100          
Purchased for cancellation
(2)
 
 
(40,866
 
 
(509
 
 
 
 
 
 
 
 
             
 
 
 
Balance at end of period
 
 
1,385,591
 
 
$
17,318
 
 
     $
4.96
 
 
 
 
 
    1,425,187     $ 17,728          $ 4.32  
Treasury – common shares
                                                       
Balance at beginning of period
(3)
 
 
(662
 
$
(73
                    (1,388   $ (129        
Purchases
 
 
(48,437
 
 
(5,183
                    (37,603     (4,060        
Sales
 
 
46,419
 
 
 
4,922
 
 
 
 
 
 
 
 
 
    38,329       4,116    
 
 
 
Balance at end of period
(3)
 
 
(2,680
 
$
(334
 
 
 
 
 
 
 
 
    (662   $ (73  
 
 
 
Common shares outstanding
 
 
1,382,911
 
 
$
16,984
 
 
 
 
 
 
 
 
 
    1,424,525     $ 17,655    
 
 
 
Preferred shares and other equity instruments issued
                                                       
First preferred
(4)
                                                       
Non-cumulative,
fixed rate
                                                       
Series BH
 
 
6,000
 
 
$
150
 
 
$
1.23
 
            6,000     $ 150     $ 1.23  
Series BI
 
 
6,000
 
 
 
150
 
 
 
1.23
 
            6,000       150       1.23  
Series BJ
(5)
 
 
 
 
 
 
 
 
0.33
 
            6,000       150       1.31  
Non-cumulative,
5-Year
Rate Reset
                                                       
Series AZ
 
 
20,000
 
 
 
500
 
 
 
0.93
 
            20,000       500       0.93  
Series BB
 
 
20,000
 
 
 
500
 
 
 
0.91
 
            20,000       500       0.91  
Series BD
 
 
24,000
 
 
 
600
 
 
 
0.80
 
            24,000       600       0.80  
Series BF
 
 
12,000
 
 
 
300
 
 
 
0.75
 
            12,000       300       0.75  
Series BO
 
 
14,000
 
 
 
350
 
 
 
1.20
 
            14,000       350       1.20  
Series BT
(6)
 
 
750
 
 
 
750
 
 
 
4.20%
 
                         
Non-cumulative,
fixed rate/floating rate
                                                       
Series
C-2
 
 
15
 
 
 
23
 
 
US$
  67.50
 
            15       23     US$   67.50  
Other equity instruments
                                                       
Limited recourse capital notes (LRCNs) 
(7)
                                                       
Series 1
(8)
 
 
1,750
 
 
 
1,750
 
 
 
4.50%
 
            1,750       1,750       4.50%  
Series 2
(8)
 
 
1,250
 
 
 
1,250
 
 
 
4.00%
 
            1,250       1,250       4.00%  
Series 3
(8)
 
 
1,000
 
 
 
1,000
 
 
 
3.65%
 
 
 
 
 
    1,000       1,000       3.65%  
 
 
 
106,765
 
 
$
7,323
 
 
 
 
 
 
 
 
 
    112,015     $ 6,723    
 
 
 
Treasury – preferred shares and other equity instruments
                                                       
Balance at beginning of period
(3)
 
 
(164
 
$
(39
                    (2   $ (3        
Purchases
 
 
(2,811
 
 
(518
                    (6,306     (683        
Sales
 
 
2,963
 
 
 
552
 
 
 
 
 
 
 
 
 
    6,144       647    
 
 
 
Balance at end of period
(3)
 
 
(12
 
$
(5
 
 
 
 
 
 
 
 
    (164   $ (39  
 
 
 
Preferred shares and other equity instruments outstanding
 
 
106,753
 
 
$
7,318
 
 
 
 
 
 
 
 
 
    111,851     $ 6,684    
 
 
 
 
(1)   Includes fair value adjustments to stock options of $6 million (October 31, 2021 – $11 million).
(2)   During the year ended October 31, 2022, we purchased common shares for cancellation at an average cost of $132.80 per share with a book value of $12.47 per share. During the year ended October 31, 2021, we did not purchase for cancellation any common shares.
(3)   Positive amounts represent a short position and negative amounts represent a long position.
(4)   First Preferred Shares were issued at $25 per share with the exception of
Non-Cumulative
5-
Y
ear
Rate Reset First Preferred Shares Series BT (Series BT) and
Non-Cumulative
Fixed Rate/Floating Rate First Preferred Shares Series
C-2
(Series
C-2)
which were issued at $1,000 and US$1,000 per share (equivalent to US$25 per depositary share), respectively.
(5)   On February 24, 2022, we redeemed all 6 million of our issued and outstanding
Non-Cumulative
Fixed Rate First Preferred Shares Series BJ at a price of $25.75 per share.
(6)   On November 5, 2021, we issued 750 thousand
Non-Cumulative
5-
Y
ear
Rate Reset First Preferred Shares Series BT, totalling $750 million.
(7)   Each series of LRCNs (LRCN Series) were issued at a $1,000 per note. The number of shares represent the number of notes issued and the dividends declared per share represent the annual interest rate percentage applicable to the notes issued as at the reporting date.
(8)   In connection with the issuance of LRCN Series 1, we issued $1,750 million of
Non-Cumulative
5-Year
Rate Reset First Preferred Shares Series BQ (Series BQ); in connection with the issuance of LRCN Series 2, we issued $1,250 million of
Non-Cumulative
5-Year
Rate Reset First Preferred Shares Series BR (Series BR); in connection with the issuance of LRCN Series 3, we issued $1,000 million of
Non-Cumulative
5-Year
Rate Reset First Preferred Shares Series BS (Series BS). The Series BQ, BR and BS preferred shares were issued at a price of $1,000 per share and were issued to a consolidated trust to be held as trust assets in connection with each respective LRCN Series.
 
Summary of Significant Terms and Conditions of Preferred Shares and Other Equity Instruments
Significant terms and conditions of preferred shares and other equity instruments
 
             
As at October 31, 2022
 
Current
annual yield
    
Premium
    
Current
dividend
per share 
(1)
    
Earliest
redemption
date
(2)
    
Issue date
    
Redemption
price
(2)
,
(3)
 
Preferred shares
                                                    
First preferred
                                                    
Non-cumulative,
fixed rate
                                                    
Series BH
(4)
    4.90%                    $ .306250        November 24, 2020        June 5, 2015           $ 26.00  
Series BI
(4)
    4.90%                 .306250        November 24, 2020        July 22, 2015        26.00  
Non-cumulative,
5-Year
Rate Reset
(5)
                                                    
Series AZ
(4)
    3.70%        2.21%        .231250        May 24, 2019        January 30, 2014        25.00  
Series BB
(4)
    3.65%        2.26%        .228125        August 24, 2019        June 3, 2014        25.00  
Series BD
(4)
    3.20%        2.74%        .200000        May 24, 2020        January 30, 2015        25.00  
Series BF
(4)
    3.60%        2.62%        .187500        November 24, 2020        March 13, 2015        25.00  
Series BO
(4)
    4.80%        2.38%        .300000        February 24, 2024        November 2, 2018        25.00  
Series BT
(4)
    4.20%        2.71%        21.000000        February 24, 2027        November 5, 2021        1,000.00  
Non-cumulative,
fixed rate/floating rate
                                                    
Series
C-2
(6)
    6.75%        4.052%      US$ 16.875000        November 7, 2023        November 2, 2015      US$ 1,000.00  
Other equity instruments
                                                    
Limited recourse capital notes 
(7)
                                                    
Series 1
(8)
    4.50%        4.137%        n.a.        October 24, 2025        July 28, 2020           $ 1,000.00  
Series 2
(9)
    4.00%        3.617%        n.a.        January 24, 2026        November 2, 2020        1,000.00  
Series 3
(10)
    3.65%        2.665%        n.a.        October 24, 2026        June 8, 2021        1,000.00  
 
(1)   With the exception of Series BT,
non-cumulative
preferential dividends of each Series are payable quarterly, as and when declared by the Board of Directors, on or about the 24th day (7th day for Series
C-2)
of February, May, August and November. In the case of Series BT,
non-cumulative
preferential dividends are payable semi-annually, as and when declared by the Board of Directors.
(2)   Subject to the consent of OSFI and the requirements of the Bank Act (Canada), we may, on or after the dates specified above, redeem First Preferred Shares. In the case of Series AZ, BB, BD, BF, and BO, these may be redeemed for cash at a price per share of $25 if redeemed on the earliest redemption date and on the same date every fifth year thereafter. In the case of BH and BI, these may be redeemed for cash at a price per share of $26 if redeemed during the 12 months commencing on the earliest redemption date and decreasing by $0.25 each
12-month
period thereafter to a price per share of $25 if redeemed four years from the earliest redemption date or thereafter. Series BT may be redeemed for cash at a price per share of $1,000 if redeemed on the earliest redemption date and on the same date every fifth year thereafter. Series
C-2
may be redeemed at a price of US$1,000 on the earliest redemption date and any dividend payment date thereafter.
(3)   Subject to the consent of OSFI and the requirements of the Bank Act (Canada), we may purchase the First Preferred Shares of each Series for cancellation at the lowest price or prices at which, in the opinion of the Board of Directors, such shares are obtainable.
(4)   The preferred shares include NVCC provisions, necessary for the shares to qualify as Tier 1 regulatory capital under Basel III. NVCC provisions require the conversion of the instrument into a variable number of common shares in the event that OSFI deems the Bank
non-viable
or a federal or provincial government in Canada publicly announces that the Bank has accepted or agreed to accept a capital injection. In such an event, each preferred share is convertible into common shares pursuant to an automatic conversion formula with a multiplier of 1 and with a conversion price based on the greater of: (i) a floor price of $5 and (ii) the current market price of our common shares based on the volume weighted average trading price of our common shares on the Toronto Stock Exchange. The number of shares issued is determined by dividing the preferred share value by the conversion price.
(5)   The dividend rate will reset on the earliest redemption date and every fifth year thereafter at a rate equal to the
5-year
Government of Canada bond yield plus the premium indicated. The holders have the option to convert their shares into
non-cumulative
floating rate First Preferred Shares subject to certain conditions on the earliest redemption date and every fifth year thereafter at a rate equal to the three-month Government of Canada Treasury Bill rate plus the premium indicated.
(6)   The dividend rate will change on the earliest redemption date at a rate equal to the
3-month
LIBOR plus the premium indicated. Series
C-2
do not qualify as Tier 1 regulatory capital.
(7)   The current annual yield on each LRCN Series represents the annual interest rate applicable to the notes issued as at the reporting date. The payments of interest and principal in cash on the LRCN Series are made at our discretion, and
non-payment
of interest and principal in cash does not constitute an event of default. In the event of
(i) non-payment
of interest on any interest payment date,
(ii) non-payment
of the redemption price in case of a redemption of a LRCN Series,
(iii) non-payment
of principal at the maturity of a LRCN Series, or (iv) an event of default on a LRCN Series, holders of such LRCN Series will have recourse only to the assets (Trust Assets) held by a third-party trustee in a consolidated trust in respect of such LRCN Series and each such noteholder will be entitled to receive its pro rata share of the Trust Assets. In such an event, the delivery of the Trust Assets for each LRCN Series will represent the full and complete extinguishment of our obligations under the related LRCN Series. The LRCNs include NVCC provisions, necessary for the shares to qualify as Tier 1 regulatory capital under Basel III. NVCC provisions require the conversion of the instrument into a variable number of common shares in the event that OSFI deems the Bank
non-viable
or a federal or provincial government in Canada publicly announces that the Bank has accepted or agreed to accept a capital injection. In such an event, each note is automatically redeemed and the redemption price will be satisfied by the delivery of Trust Assets, which will consist of common shares pursuant to an automatic conversion of the series of preferred shares that were issued concurrently with the related LRCN Series. Each series of preferred shares include an automatic conversion formula with a conversion price based on the greater of: (i) a floor price of $5 and (ii) the current market price of our common shares based on the volume weighted average trading price of our common shares on the Toronto Stock Exchange. The number of common shares issued in respect of each series of preferred shares will be determined by dividing the preferred share value ($1,000 plus declared and unpaid dividends) by the conversion price. The number of common shares delivered to each noteholder will be based on such noteholder’s pro rata interest in the Trust Assets. Subject to the consent of OSFI, we may purchase LRCNs for cancellation at such price or prices and upon such terms and conditions as we in our absolute discretion may determine, subject to any applicable law restricting the purchase of notes.
(8)   LRCN Series 1 bear interest at a fixed rate of 4.5% per annum until November 24, 2025, and thereafter at a rate per annum, reset every fifth year, equal to the
5-Year
Government of Canada Yield plus 4.137% until maturity on November 24, 2080. The interest is paid semi-annually on or about the 24th day of May and November. LRCN Series 1 is redeemable during the period from October 24 to and including November 24, commencing in 2025 and every fifth year thereafter to the extent we redeem Series BQ pursuant to their terms and subject to the consent of OSFI and requirements of the Bank Act (Canada).
(9)   LRCN Series 2 bear interest at a fixed rate of 4.0% per annum until February 24, 2026, and thereafter at a rate per annum, reset every fifth year, equal to the
5-Year
Government of Canada Yield plus 3.617% until maturity on February 24, 2081. The interest is paid semi-annually on or about the 24th day of February and August. LRCN Series 2 is redeemable during the period from January 24 to and including February 24, commencing in 2026 and every fifth year thereafter to the extent we redeem Series BR pursuant to their terms and subject to the consent of OSFI and requirements of the Bank Act (Canada).
(10)   LRCN Series 3 bear interest at a fixed rate of 3.65% per annum until November 24, 2026, and thereafter at a rate per annum, reset every fifth year, equal to the
5-Year
Government of Canada Yield plus 2.665% until maturity on November 24, 2081. The interest is paid semi-annually on or about the 24th day of May and November. LRCN Series 3 is redeemable during the period from October 24 to and including November 24, commencing in 2026 and every fifth year thereafter to the extent we redeem Series BS pursuant to their terms and subject to the consent of OSFI and requirements of the Bank Act (Canada).
n.a.   not applicable